MCTS1 and breast carcinoma: We found that the majority of methylation sites in the DNA sequences of MCTS1 were hypomethylated in breast cancer, and the degree of methylation was correlated with patient outcomes (i.e., patients with low MCTS1 methylation had poorer overall survival than patients with high MCTS1 methylation) (Figure 6B).